Kenneth J Sultzbaugh

Title: The Innovative Journey of Kenneth J. Sultzbaugh

Introduction

Kenneth J. Sultzbaugh is an accomplished inventor based in Bridgewater, NJ, with a notable portfolio of three patents. His work primarily focuses on pharmaceutical innovations, particularly in creating effective dosage forms for medication. With a commitment to enhancing patient care, Sultzbaugh has developed technologies that improve the delivery and efficacy of therapeutics.

Latest Patents

One of Kenneth's latest inventions is the rapidly dispersible dosage form of oxcarbazepine. This innovation introduces a high-dose orodispersible dosage form that includes drug-containing particles of oxcarbazepine encapsulated within a porous bound matrix. The unique feature of this dosage form is its ability to disperse in saliva or water in less than 15 seconds, combined with sufficient hardness to withstand handling and storage. This formulation is particularly beneficial for treating diseases or disorders that respond to oxcarbazepine or its derivatives, showcasing Sultzbaugh's dedication to creating accessible and effective treatments.

Career Highlights

Kenneth has made significant contributions to the field of pharmaceuticals through his work at Aprecia Pharmaceuticals, both at the company level and its LLC counterpart. His expertise in developing practical delivery systems for medications demonstrates his skill as an inventor and his commitment to advancing medical therapies.

Collaborations

Throughout his career, Kenneth has collaborated with notable professionals in the industry, including his coworkers Jules S. Jacob and Kelly E. Caputo. These collaborations have played a crucial role in refining and enhancing his inventions, leading to breakthroughs in drug formulation and delivery systems.

Conclusion

Kenneth J. Sultzbaugh's innovative spirit and dedication to improving pharmaceutical formulations have yielded significant advancements in medication delivery. His expertise is evident through his patents and collaborations, paving the way for future developments that aim to enhance therapeutic outcomes for patients. As he continues to push the boundaries of innovation, Sultzbaugh remains a vital contributor to the world of pharmaceuticals.